Drugs modulating the L-arginine:NO:cGMP pathway – current use in therapy
Nitric oxide (NO) is a relatively novel messenger that plays a significant role in a wide range of physiological processes. Currently, it is known that, both, lack and excess of NO can cause diseases, thus a lot of substances have been discovered and utilized which can change the concentration of th...
Main Authors: | Polakowska Magdalena, Orzelska-Gorka Jolanta, Talarek Sylwia |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-04-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/cipms-2016-0004 |
Similar Items
-
The Arginine/ADMA Ratio Is Related to the Prevention of Atherosclerotic Plaques in Hypercholesterolemic Rabbits When Giving a Combined Therapy with Atorvastatine and Arginine
by: Saskia J. H. Brinkmann, et al.
Published: (2015-05-01) -
The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol
by: G. L. Bakris, et al.
Published: (2011-04-01) -
Comparative therapeutic effect of the L-arginine and sildenafil on beta-thalassemia children with increased tricuspid regurgitant jet velocity
by: Hosny Mohammed Ahmed El-Masry, et al.
Published: (2020-06-01) -
Effects of sildenafil citrate on pancreatic and lung complications in an experimental L-arginine-induced acute pancreatitis model
by: Baris Gulturk, et al.
Published: (2021-03-01) -
The role of vasodilating β-blockers in controlling arterial hypertension as a means of reducing cardiovascular and stroke risk
by: Jan N. Basile
Published: (2011-06-01)